The Creme RIFM model provides a detailed aggregate systemic and dermal exposure assessment system for fragrance compounds. The model has data to assess exposure for consumers across Europe and the USA. The benefits to RIFM members of using this new model include:
The Creme RIFM model includes detailed usage data for over 36,000 consumers representing the European and US populations. This robust population sample allows generation of accurate and realistic exposure results. The database contains detailed usage information on the following products: